Literature DB >> 35907168

Advantages of the umbilical minilaparotomy-first approach in robotic rectal cancer surgery.

Yukiharu Hiyoshi1, Tomohiro Yamaguchi2, Nobuko Matsuura3, Takahiro Amano1, Takumi Kozu1, Toshiki Mukai1, Toshiya Nagasaki1, Takashi Akiyoshi1, Yosuke Fukunaga1.   

Abstract

BACKGROUND: Since 2018, we have performed robotic rectal cancer surgery at our institution via the umbilical mini-laparotomy-first approach. In the present technical note, we introduce the advantages of this approach.
METHODS: In this approach, a 3-cm mini-laparotomy and the wound protector attachment are performed prior to port placement for the da Vinci® Xi system. During robotic surgery, the assistant can adjust the location of the camera port within the wound protector.
RESULTS: This approach is only different from the standard port placement in terms of the timing of minilaparotomy; therefore, there is no additional cost. This approach has several advantages. 1: Intraabdominal adhesion around the umbilicus can be dissected under direct vision. 2: Robot arm collision can be diminished. 3: The diverting stoma can be located just at the preoperative stoma-site marking. 4: The da Vinci® camera is less likely to be dirty. 5: Assistant ports can be added through the wound protector. However, sometimes interference between the wound protector extends inside the abdomen and other ports can be a problem, especially in small patients. A smaller-size wound protector is thus recommended in such cases.
CONCLUSIONS: The umbilical minilaparotomy-first approach in robotic rectal cancer surgery is a simple and feasible technique with great advantages for not only ensuring successful robotic surgery but also reducing the stoma-associated complications.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Rectal cancer; Robotic surgery; Stoma; Umbilical minilaparotomy first approach

Year:  2022        PMID: 35907168     DOI: 10.1007/s10151-022-02662-5

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.699


  7 in total

1.  Robotic-assisted vs. conventional laparoscopic surgery for rectal cancer: short-term outcomes at a single center.

Authors:  Tomohiro Yamaguchi; Yusuke Kinugasa; Akio Shiomi; Hiroyuki Tomioka; Hiroyasu Kagawa; Yushi Yamakawa
Journal:  Surg Today       Date:  2015-10-19       Impact factor: 2.549

Review 2.  Laparoscopic vs. robotic rectal cancer surgery and the effect on conversion rates: a meta-analysis of randomized controlled trials and propensity-score-matched studies.

Authors:  K Phan; H R Kahlaee; S H Kim; J W T Toh
Journal:  Tech Coloproctol       Date:  2019-01-08       Impact factor: 3.781

3.  Robotic extralevator abdominoperineal resection with en bloc multivisceral resection and lateral lymph node dissection for rectal cancer.

Authors:  T Yamaguchi; T Akiyoshi; Y Fukunaga; S Nagayama; T Nagasaki; T Mukai; R Nakanishi; T Konishi
Journal:  Tech Coloproctol       Date:  2020-05-30       Impact factor: 3.781

4.  Open Versus Laparoscopic Versus Robotic Versus Transanal Mesorectal Excision for Rectal Cancer: A Systematic Review and Network Meta-analysis.

Authors:  Constantinos Simillis; Nikhil Lal; Sarah N Thoukididou; Christos Kontovounisios; Jason J Smith; Roel Hompes; Michel Adamina; Paris P Tekkis
Journal:  Ann Surg       Date:  2019-07       Impact factor: 12.969

5.  Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Francesco Paolo Prete; Angela Pezzolla; Fernando Prete; Mario Testini; Rinaldo Marzaioli; Alberto Patriti; Rosa Maria Jimenez-Rodriguez; Angela Gurrado; Giovanni F M Strippoli
Journal:  Ann Surg       Date:  2018-06       Impact factor: 12.969

6.  Is robotic da Vinci Xi® superior to the da Vinci Si® for sphincter-preserving total mesorectal excision? Outcomes in 150 mid-low rectal cancer patients.

Authors:  Vusal Aliyev; Naciye Cigdem Arslan; Beslen Goksoy; Koray Guven; Suha Goksel; Oktar Asoglu
Journal:  J Robot Surg       Date:  2022-02-02

7.  The oncological and surgical safety of robot-assisted surgery in colorectal cancer: outcomes of a longitudinal prospective cohort study.

Authors:  F Polat; L H Willems; K Dogan; C Rosman
Journal:  Surg Endosc       Date:  2019-01-28       Impact factor: 4.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.